CASTLIGHT HEALTH, INC. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Goodwill impairment
Stock-based compensation
Amortization of deferred commissions
Amortization and impairment of deferred commissions
Amortization and impairment of deferred professional service costs
Non-cash operating lease expense
Release of deferred tax valuation allowance due to business combination
Lease exit and related charges
Change in fair value of contingent consideration liability
Accretion and amortization of marketable securities
Expense related to expiration of SAP warrant
Gain on sale of investment in related party
Changes in operating assets and liabilities:
Accounts receivable and other, net
Deferred commissions
Deferred professional service costs
Prepaid expenses and other assets
Accounts payable
Operating lease liabilities
Accrued expenses and other liabilities
Deferred revenue
Accrued compensation

Net cash used in operating activities
Increase (Decrease) in Restricted Cash
Investing activities:
Proceeds from sale of investment in related party
Investment in related party
Purchase of property and equipment, net
Purchase of marketable securities
Sales of marketable securities
Maturities of marketable securities
Business combination, net of cash acquired
Net cash provided by (used in) investing activities

Financing activities:
Proceeds from initial public offering
Proceeds from exercise of stock options
Proceeds from the issuance of common stock and warrants to SAP
Proceeds from ESPP offering
Principal payments on debt
Payments of issuance costs related to equity
Net cash (used in) provided by financing activities
Net increase (decrease) in cash and cash equivalents

Cash and cash equivalents
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental cash flow information:
Cash paid for interest
Non-cash purchase consideration related to acquisition of Jiff
Purchase of property and equipment, accrued but not paid
Deferred offering costs, accrued but not paid
Right-of-use assets obtained in exchange for new operating lease liabilities, net

Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Vesting of early exercised stock options, restricted common stock, and warrants
Restricted cash included in Prepaid expenses and other current assets
Restricted cash, non-current

Comments